Access the list of approved Gilead therapies across virology including HIV, liver disease including hepatitis and primary biliary cholangitis, oncology & inflammation.

Gilead Sciences, Inc. (/ ˈɡɪliəd /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

Pill with imprint GILEAD 701 is Blue, Capsule/Oblong and has been identified as Truvada 200 mg / 300 mg. It is supplied by Gilead Sciences. Truvada is used in the treatment of Pre-Exposure Prophylaxis; Occupational Exposure; HIV Infection; Nonoccupational Exposure and belongs to the drug class antiviral combinations. There is no proven risk in ...

2025年2月18日 · Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly.

This blue capsule-shape pill with imprint GILEAD 701 on it has been identified as: Truvada 200 mg / 300 mg. This medicine is known as Truvada (generic name: emtricitabine/tenofovir). It is available as a prescription only medicine and is commonly used for HIV Infection, Nonoccupational Exposure, Occupational Exposure, Pre-Exposure Prophylaxis.

2024年6月20日 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, demonstrated 100% efficacy for the investigational use of HIV prevention in cisgen...

Pill Identifier results for "gilead". Search by imprint, shape, color or drug name.

Please refer to each medication’s prescribing information and medication guide or patient information for specific details. To report an adverse event, please call 1‑800‑445‑3235 (option #3) 24 hours/day, 7 days/week. efavirenz 600 mg/emtricitabine 200 mg/tenofovlr disoproxil fumarate 300 mg.

Search for easy-to-access information on Gilead medicines. Use the call, inquire, and chat functions to connect with a Gilead Medical representative.

2024年9月12日 · In a Phase 3 clinical trial, 99.9% of participants who took a twice-a-year injection of lenacapavir for HIV prevention did not acquire an infection, according to data from drugmaker Gilead...